Advances in the management of fibromyalgia.
In summary, new FDA approvals offer options for the treatment of FM. CNS targets have proven to be effective in the treatment of FM. However, treatment must be individualized and the integration of various pharmacologic and nonpharmacologic treatments may be the best approach.
Arnold
Lesley M
LM
Women's Health Research Program, University of Cincinnati College of Medicine, Ohio, USA.
D018759:Adrenergic Uptake Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D000465:Algorithms; D000700:Analgesics / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects / Q000627:therapeutic use; D015928:Cognitive Behavioral Therapy; D003131:Combined Modality Therapy; D003937:Diagnosis, Differential; D015444:Exercise; D005260:Female; D005356:Fibromyalgia / Q000175:diagnosis / Q000628:therapy*; D006801:Humans; D008875:Middle Aged; D010147:Pain Measurement; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000627:therapeutic use
D018759:Adrenergic Uptake Inhibitors; D000700:Analgesics; D000929:Antidepressive Agents, Tricyclic; D017367:Selective Serotonin Reuptake Inhibitors